NewsRoom Articles - Page 192 of 235

WednesdayMar 17, 2021 3:15 pm

University of Louisiana-Monroe to Launch Biomedical Research Park with Partners

Several economic development figures and public officials recently established a research park to help attract science, technology and biomedical companies to Monroe, Louisiana. The not-for-profit organization launched the Biomedical Research and Innovation Park, which would collaborate with the University of Louisiana-Monroe and would inhabit a proposed facility near the institution’s College of Pharmacy facility. Monroe’s Dr. Ray Armstrong, who was the lead in the creation of the research park, stated that the park would not only focus on biomedical research but that its objective would be to encourage innovation in every field and promote economic development throughout Northeast Louisiana. University…

WednesdayMar 17, 2021 2:01 pm

Imagin Medical (CSE: IME) (OTCQB: IMEXF), With Their Advanced i/Blue(TM) Imaging System, Closes Second Tranche of Convertible Note Offering

Imagin Medical is a surgical company focused on developing its i/Blue(TM) Imaging System, employing patented ultrasensitive imaging technology The i/Blue(TM) Imaging System is system compatible; system attaches to most endoscopes The company recently closed the second tranche for the amount of US$1,415,500 of the Convertible Note offering Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive surgical procedures. Imagin Medical is run by an experienced management team that is preparing their i/Blue(TM) Imaging System for the industry. An FDA approval process is underway. The company’s patented ultrasensitive…

TuesdayMar 16, 2021 2:36 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Brain cancer drug developer CNS Pharmaceuticals is finalizing preparations to begin March enrollment of patients in its potentially pivotal Phase 2 trial evaluating its promising lead candidate, Berubicin, for the overall survival improvement of glioblastoma (“GBM”) patients Glioblastomas are a type of brain cancer that have continued to elude effective therapy over the past century of investigation, leaving patients with expectations of approximately 15 months of survivability beyond diagnosis and recurrence after surgical removal A GBM patient in a small Phase 1 Berubicin safety trial 15 years ago has remained cancer-free and stable as of last November, a hint of…

MondayMar 15, 2021 3:15 pm

Washington University Awarded $3.1 Million Grant for ALS Research

The National Institute of Neurological Disorders and Stroke, which is a National Institutes of Health affiliate, recently awarded researchers from St. Jude Children’s Research Hospital and Washington University in St. Louis a $3.1 million grant. Tanja Mittag, of the Department of Structural Biology at St. Jude and Washington University’s Rohit Pappu, who is an engineering professor in the McKelvey School of Engineering, collected the funds, which would enable the team to research RNA-binding proteins that mutate in individuals with genetic forms of Lou Gehrig’s disease, also referred to as amyotrophic lateral sclerosis. The objective is to discover the basic process…

MondayMar 15, 2021 2:16 pm

Healthy Extracts Inc. (HYEX) Reports 71% Revenue Increase Backed by Industry Momentum

Healthy Extracts Inc. officially changed its name from Grey Cloak Tech Inc. on March 1, formalizing the company’s shift into the health products industry Healthy Extracts currently wholly owns two subsidiaries, BergaMet North America (“NA”) and Ultimate Brain Nutrients (“UBN”), and reported a revenue increase of 71% from $748,377 in 2019 to $1,276,559 in the 12 months ending December 31, 2020 This revenue growth is consistent with the trend in the plant-based foods and products industry, which is growing due to increased health consciousness and concerns regarding climate change The plant-based foods and products industry is experiencing a boom attributable…

MondayMar 15, 2021 12:18 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Revolutionary Technology a Cost Saver for Hospitals and Patients

White light cystoscopy (“WLC”) is the most commonly used procedure to detect non-muscle invasive bladder cancer (“NMIBC”) Despite its prevalence, WLC is not the most effective method and contributes to a high bladder cancer recurrence rate Blue light cystoscopy (“BLC”) is a more recent and highly effective method, but the high cost of equipment and skill level has impeded its uptake among hospitals Imagin Medical believes the i/Blue(TM) Imaging System , which displays white and blue light images side by side, will address these issues It eliminates the need to purchase new cystoscopes. The i/Blue System’s dual-view camera head can…

FridayMar 12, 2021 3:15 pm

Engineers at Buffalo University Close to Using 3D Printing to Make Human Organs

Engineers from the University at Buffalo have designed a technology that allows 3D-printed human organs and tissues to be developed at a pace that is almost 50 times faster than the current industry standard. This biotechnology could be used to save lives that may have otherwise been lost due to donor organ shortages. Associate professor of biomedical engineering and the co-lead author of the study Ruogang Zhao explained that the technology also worked with big sample sizes, which was not easy to achieve prior to the technology’s invention. The study was reported in the “Advanced Healthcare Materials” journal in February.…

FridayMar 12, 2021 12:41 pm

Brain Scientific Inc. (BRSF) Meeting Need for Disposable Technology

COVID-19 has increased the need for disposable neurological technology Currently no way exists to ensure electrodes are free of contamination when using traditional reusable EEGs Neurological manifestations have presented themselves in 82% of hospitalized COVID-19 Brain Scientific (OTCQB: BRSF) is a commercial-stage, health-care company modernizing the brain diagnostic market through cutting-edge technologies. The company is fulfilling a growing need for improved brain monitoring that is cost efficient, disposable and portable. Neurological conditions are on the rise, increasing the need for an already sparse supply of specialized neurologists. COVID-19 has increased the need for disposable neurological technology that is accessible to…

ThursdayMar 11, 2021 2:20 pm

Brain Scientific Inc. (BRSF) Teams Up with Ehave Inc. to Leverage Use of AI in Mental Health Space

BRSF signed MOU with leading provider of digital therapeutics for mental health sector to use data, AI to advance work in mental health disorders Company will provide proprietary NeuroCap, NeuroEEG devices to collect, transfer data from patients Collaboration could expand into a number of clinical and commercial applications Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company developing products related to the brain including neurology, AI and machine learning, has signed a memorandum of understanding (“MoU”) with Ehave Inc. (OTC: EHVVF), a provider of digital therapeutics for the mental health sector (https://ibn.fm/ktiLG). The two companies aim to collaborate by using data and…

WednesdayMar 10, 2021 1:55 pm

Life-Saving Invention Simplifies Treatment of Heart Disease

An irregular heartbeat, which is scientifically termed as a cardiac arrhythmia, can begin at a moment’s notice before rapidly becoming worse. A couple of decades ago, in the ‘60s, a physician by the name of L. Julian Haywood found a way to monitor an individual’s heart continuously, watching for a change in its rhythm and then alerting doctors and nurses when an anomaly was found. Before that, in 1956, Haywood was in year two of his internal medicine residency at the Los Angeles County General Hospital. He had concluded his residency at the Howard University and the University of Virginia…